True Wealth Design, LLC Nektar Therapeutics Transaction History
True Wealth Design, LLC
- $327 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
19Shares Held
15.6MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY15.2MShares$859 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$18.5 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$2.92 Million0.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO12KShares$680,1600.0% of portfolio
-
Ropes Wealth Advisors LLC Boston, MA11.6KShares$656,3540.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $10.6B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...